Hypertrophy, Left Ventricular
"Hypertrophy, Left Ventricular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Descriptor ID |
D017379
|
| MeSH Number(s) |
C14.280.195.400 C23.300.775.250.400
|
| Concept/Terms |
Hypertrophy, Left Ventricular- Hypertrophy, Left Ventricular
- Left Ventricular Hypertrophy
- Hypertrophies, Left Ventricular
- Left Ventricular Hypertrophies
- Ventricular Hypertrophies, Left
- Ventricular Hypertrophy, Left
|
Below are MeSH descriptors whose meaning is more general than "Hypertrophy, Left Ventricular".
Below are MeSH descriptors whose meaning is more specific than "Hypertrophy, Left Ventricular".
This graph shows the total number of publications written about "Hypertrophy, Left Ventricular" by people in this website by year, and whether "Hypertrophy, Left Ventricular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 5 | 2 | 7 |
| 2003 | 3 | 0 | 3 |
| 2004 | 4 | 0 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 2 | 3 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 2 | 2 |
| 2011 | 2 | 2 | 4 |
| 2012 | 4 | 0 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 2 | 4 |
| 2015 | 3 | 2 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertrophy, Left Ventricular" by people in Profiles.
-
Fibroblast-specific TGF-? signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice. Cardiovasc Res. 2024 Dec 14; 120(16):2047-2063.
-
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies. Eur J Heart Fail. 2023 Dec; 25(12):2144-2163.
-
Arterial stiffness but not carotid intima-media thickness progression precedes premature structural and functional cardiac damage in youth: A 7-year temporal and mediation longitudinal study. Atherosclerosis. 2023 09; 380:117197.
-
Intensive Blood Pressure Lowering in?Patients With Malignant Left?Ventricular?Hypertrophy. J Am Coll Cardiol. 2022 10 18; 80(16):1516-1525.
-
Reclassification of adolescent hypertension by ambulatory blood pressure monitoring using adult norms and association with left ventricular hypertrophy. J Clin Hypertens (Greenwich). 2021 02; 23(2):265-271.
-
Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy. Cardiovasc Drugs Ther. 2020 12; 34(6):835-848.
-
Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats. J Am Heart Assoc. 2020 04 07; 9(7):e015154.
-
The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020 06 09; 141(23):1930-1936.
-
Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study. Circulation. 2020 03 24; 141(12):957-967.
-
Predictors and Consequences of Pediatric Hypertension: Have Advanced Echocardiography and Vascular Testing Arrived? Curr Hypertens Rep. 2019 05 27; 21(7):54.